Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LIGAND PHARMACEUTICALS INC Director's Dealing 2015

May 14, 2015

31289_dirs_2015-05-14_d286f77b-24ae-4a19-ada8-23429c7e2204.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2015-05-12

Reporting Person: DeSilva Nishan M (VP, Finance & Strategy and CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-05-12 Common Stock M 14214.0 $14.47 Acquired 36496 Direct
2015-05-12 Common Stock S 14214.0 $84.44 Disposed 22282 Direct
2015-05-12 Common Stock M 9306.0 $21.92 Acquired 31588 Direct
2015-05-12 Common Stock S 9306.0 $84.91 Disposed 22282 Direct
2015-05-13 Common Stock M 12148.0 $21.92 Acquired 34430 Direct
2015-05-13 Common Stock S 12148.0 $83.23 Disposed 22282 Direct
2015-05-13 Common Stock M 11757.0 $14.47 Acquired 34039 Direct
2015-05-13 Common Stock S 11757.0 $83.32 Disposed 22282 Direct
2015-05-14 Common Stock M 20938.0 $74.42 Acquired 43220 Direct
2015-05-14 Common Stock S 20938.0 $83.84 Disposed 22282 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-05-12 Employee Stock Option (right to buy) $14.47 M 14214.0 Disposed 2022-02-09 Common Stock (14214) Direct
2015-05-13 Employee Stock Option (right to buy) $14.47 M 11757.0 Disposed 2022-02-09 Common Stock (11757) Direct
2015-05-12 Employee Stock Option (right to buy) $21.92 M 9306.0 Disposed 2023-02-15 Common Stock (9306) Direct
2015-05-13 Employee Stock Option (right to buy) $21.92 M 12148.0 Disposed 2023-02-15 Common Stock (12148) Direct
2015-05-14 Employee Stock Option (right to buy) $74.42 M 20938.0 Disposed 2024-02-12 Common Stock (20938) Direct

Footnotes

F1: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/09/12.

F2: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/15/13.

F3: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/12/14.